Table 2.

Comparison between both groups regarding short-term morbidity and mortality

	No Ivabradine (n = 656)	Ivabradine (n = 342)	P-value
Hospital stay (days)	7.7 ± 5.6	5.3 ± 2.3	< 0.0001*
Re-hospitalization (30 days)	8 (1.2)	2 (0.6)	0.36
Death (30 days)	2 (0.3)	0 (0)	0.31
Re-hospitalization (180 days)	24 (3.7)	10 (2.9)	0.51
Death (180 days)	6 (0.9)	1 (0.3)	0.28

Data are represented in number (%) or mean ± S.D.

^*Significant P-value < 0.05.